Article
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
The American journal of pathology - 1 Mar 2001
Garcia-Rostan G, Camp R L, Herrero A, Carcangiu M L, Rimm D L, Tallini G
Abstract excerpt
beta-catenin has a role in cell adhesion and Wnt signaling. It is mutated or otherwise dysregulated in a variety of human cancers. In this study we assess beta-catenin alteration in 145 thyroid tumors samples from 127 patients. beta-catenin was localized using immunofluorescence and mutational analysis was performed by single-strand conformational polymorphism. Membrane beta-catenin expression was decreased in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
